114373-07-8 Usage
Description
(3-Methylpyrrolidin-3-yl)MethanaMine, also known as N-(3-Methylpyrrolidin-3-yl)methanamine, is a chemical compound with the molecular formula C6H13N. It is a colorless to pale yellow liquid with a distinct odor and is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds.
Uses
Used in Pharmaceutical Industry:
(3-Methylpyrrolidin-3-yl)MethanaMine is used as a chemical intermediate for the synthesis of various drugs and drug intermediates, contributing to the development of new medications and improving existing ones.
Used in Organic Chemistry:
(3-Methylpyrrolidin-3-yl)MethanaMine is used as a reagent in organic chemistry, enabling the production of a range of organic compounds for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 114373-07-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,3,7 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 114373-07:
(8*1)+(7*1)+(6*4)+(5*3)+(4*7)+(3*3)+(2*0)+(1*7)=98
98 % 10 = 8
So 114373-07-8 is a valid CAS Registry Number.
114373-07-8Relevant articles and documents
Synthesis and structural optimization of 7-(3,3-disubstituted-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8 -methoxy-4-oxo-3-quinolinecarboxylic acids as antibacterial agents
Kitani, Hiroyuki,Kuroda, Tsuyoshi,Moriguchi, Akihiko,Ao, Hideki,Hirayama, Fumihiro,Ikeda, Yoshifumi,Kawakita, Takeshi
, p. 515 - 520 (2007/10/03)
A series of the titled compounds were synthesized and tested for antibacterial activities in comparison with typical fluoroquinolones. (S)-3-Aminomethyl-3-fluoromethyl derivative (Y-688) was confirmed to be optimal because of being most active especially against Gram-positive bacteria including fluoroquinolone-resistant strains and showing high photostability.
7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
-
, (2008/06/13)
Novel, orally active antibacterial agents are described and characterized as 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acids or corresponding 1,8-naphthyridine derivatives as well as methods for their m
